Bioassay ontology to describe high-throughput screening assays and their results

Uma Vempati, Ubbo E Visser, Saminda Abeyruwan, Kunie Sakurai, Magdalena Przydzial, Caty Chung, Robin Smith, Ainar Koleti, Christopher Mader, Vance Lemmon, Stephan C Schuerer

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Huge amounts of high-throughput screening (HTS) data are generated in the pharmaceutical industry and more recently in the public sector. These are typically analyzed on a per-project basis. Comparison and analysis across many diverse HTS datasets are hindered by the lack of standardized descriptions of biological assays and screening results. Here, we present the BioAssay Ontology (BAO), which enables the categorization of biological assays by concepts relevant to interpret and compare HTS data and thus facilitates data analysis across many HTS campaigns. We used BAO to annotate assays from the largest public HTS data repository. PubChem. Here we demonstrate how BAO can be applied to access and analyze HTS data. BAO makes use of expressive description logic and has potential for discovering implicit knowledge using inference. BAO is publically available from the NCBO BioPortal at http://bioportal.bioontology. org/ontologies/44531.

Original languageEnglish (US)
Title of host publicationCEUR Workshop Proceedings
Pages209-216
Number of pages8
Volume833
StatePublished - 2011
Event2nd International Conference on Biomedical Ontology, ICBO 2011 - Buffalo, NY, United States
Duration: Jul 26 2011Jul 30 2011

Other

Other2nd International Conference on Biomedical Ontology, ICBO 2011
CountryUnited States
CityBuffalo, NY
Period7/26/117/30/11

Fingerprint

Bioassay
Ontology
Assays
Screening
Throughput
Drug products
Industry

Keywords

  • Assay ontology
  • Bioassay
  • Bioassay ontology
  • Biological assay
  • Biological screening
  • Data analysis
  • Description logic
  • High-throughput screening
  • HTS
  • Semantic integration

ASJC Scopus subject areas

  • Computer Science(all)

Cite this

Vempati, U., Visser, U. E., Abeyruwan, S., Sakurai, K., Przydzial, M., Chung, C., ... Schuerer, S. C. (2011). Bioassay ontology to describe high-throughput screening assays and their results. In CEUR Workshop Proceedings (Vol. 833, pp. 209-216)

Bioassay ontology to describe high-throughput screening assays and their results. / Vempati, Uma; Visser, Ubbo E; Abeyruwan, Saminda; Sakurai, Kunie; Przydzial, Magdalena; Chung, Caty; Smith, Robin; Koleti, Ainar; Mader, Christopher; Lemmon, Vance; Schuerer, Stephan C.

CEUR Workshop Proceedings. Vol. 833 2011. p. 209-216.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Vempati, U, Visser, UE, Abeyruwan, S, Sakurai, K, Przydzial, M, Chung, C, Smith, R, Koleti, A, Mader, C, Lemmon, V & Schuerer, SC 2011, Bioassay ontology to describe high-throughput screening assays and their results. in CEUR Workshop Proceedings. vol. 833, pp. 209-216, 2nd International Conference on Biomedical Ontology, ICBO 2011, Buffalo, NY, United States, 7/26/11.
Vempati U, Visser UE, Abeyruwan S, Sakurai K, Przydzial M, Chung C et al. Bioassay ontology to describe high-throughput screening assays and their results. In CEUR Workshop Proceedings. Vol. 833. 2011. p. 209-216
Vempati, Uma ; Visser, Ubbo E ; Abeyruwan, Saminda ; Sakurai, Kunie ; Przydzial, Magdalena ; Chung, Caty ; Smith, Robin ; Koleti, Ainar ; Mader, Christopher ; Lemmon, Vance ; Schuerer, Stephan C. / Bioassay ontology to describe high-throughput screening assays and their results. CEUR Workshop Proceedings. Vol. 833 2011. pp. 209-216
@inproceedings{733827d06bbd4f86b1f7dcdac5008c1b,
title = "Bioassay ontology to describe high-throughput screening assays and their results",
abstract = "Huge amounts of high-throughput screening (HTS) data are generated in the pharmaceutical industry and more recently in the public sector. These are typically analyzed on a per-project basis. Comparison and analysis across many diverse HTS datasets are hindered by the lack of standardized descriptions of biological assays and screening results. Here, we present the BioAssay Ontology (BAO), which enables the categorization of biological assays by concepts relevant to interpret and compare HTS data and thus facilitates data analysis across many HTS campaigns. We used BAO to annotate assays from the largest public HTS data repository. PubChem. Here we demonstrate how BAO can be applied to access and analyze HTS data. BAO makes use of expressive description logic and has potential for discovering implicit knowledge using inference. BAO is publically available from the NCBO BioPortal at http://bioportal.bioontology. org/ontologies/44531.",
keywords = "Assay ontology, Bioassay, Bioassay ontology, Biological assay, Biological screening, Data analysis, Description logic, High-throughput screening, HTS, Semantic integration",
author = "Uma Vempati and Visser, {Ubbo E} and Saminda Abeyruwan and Kunie Sakurai and Magdalena Przydzial and Caty Chung and Robin Smith and Ainar Koleti and Christopher Mader and Vance Lemmon and Schuerer, {Stephan C}",
year = "2011",
language = "English (US)",
volume = "833",
pages = "209--216",
booktitle = "CEUR Workshop Proceedings",

}

TY - GEN

T1 - Bioassay ontology to describe high-throughput screening assays and their results

AU - Vempati, Uma

AU - Visser, Ubbo E

AU - Abeyruwan, Saminda

AU - Sakurai, Kunie

AU - Przydzial, Magdalena

AU - Chung, Caty

AU - Smith, Robin

AU - Koleti, Ainar

AU - Mader, Christopher

AU - Lemmon, Vance

AU - Schuerer, Stephan C

PY - 2011

Y1 - 2011

N2 - Huge amounts of high-throughput screening (HTS) data are generated in the pharmaceutical industry and more recently in the public sector. These are typically analyzed on a per-project basis. Comparison and analysis across many diverse HTS datasets are hindered by the lack of standardized descriptions of biological assays and screening results. Here, we present the BioAssay Ontology (BAO), which enables the categorization of biological assays by concepts relevant to interpret and compare HTS data and thus facilitates data analysis across many HTS campaigns. We used BAO to annotate assays from the largest public HTS data repository. PubChem. Here we demonstrate how BAO can be applied to access and analyze HTS data. BAO makes use of expressive description logic and has potential for discovering implicit knowledge using inference. BAO is publically available from the NCBO BioPortal at http://bioportal.bioontology. org/ontologies/44531.

AB - Huge amounts of high-throughput screening (HTS) data are generated in the pharmaceutical industry and more recently in the public sector. These are typically analyzed on a per-project basis. Comparison and analysis across many diverse HTS datasets are hindered by the lack of standardized descriptions of biological assays and screening results. Here, we present the BioAssay Ontology (BAO), which enables the categorization of biological assays by concepts relevant to interpret and compare HTS data and thus facilitates data analysis across many HTS campaigns. We used BAO to annotate assays from the largest public HTS data repository. PubChem. Here we demonstrate how BAO can be applied to access and analyze HTS data. BAO makes use of expressive description logic and has potential for discovering implicit knowledge using inference. BAO is publically available from the NCBO BioPortal at http://bioportal.bioontology. org/ontologies/44531.

KW - Assay ontology

KW - Bioassay

KW - Bioassay ontology

KW - Biological assay

KW - Biological screening

KW - Data analysis

KW - Description logic

KW - High-throughput screening

KW - HTS

KW - Semantic integration

UR - http://www.scopus.com/inward/record.url?scp=84891939872&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891939872&partnerID=8YFLogxK

M3 - Conference contribution

AN - SCOPUS:84891939872

VL - 833

SP - 209

EP - 216

BT - CEUR Workshop Proceedings

ER -